Correlation Between Vivos Therapeutics and MultiPlan
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and MultiPlan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and MultiPlan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and MultiPlan, you can compare the effects of market volatilities on Vivos Therapeutics and MultiPlan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of MultiPlan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and MultiPlan.
Diversification Opportunities for Vivos Therapeutics and MultiPlan
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vivos and MultiPlan is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and MultiPlan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MultiPlan and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with MultiPlan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MultiPlan has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and MultiPlan go up and down completely randomly.
Pair Corralation between Vivos Therapeutics and MultiPlan
Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 0.58 times more return on investment than MultiPlan. However, Vivos Therapeutics is 1.71 times less risky than MultiPlan. It trades about 0.34 of its potential returns per unit of risk. MultiPlan is currently generating about -0.05 per unit of risk. If you would invest 321.00 in Vivos Therapeutics on September 12, 2024 and sell it today you would earn a total of 134.00 from holding Vivos Therapeutics or generate 41.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Vivos Therapeutics vs. MultiPlan
Performance |
| Timeline |
| Vivos Therapeutics |
| MultiPlan |
Vivos Therapeutics and MultiPlan Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vivos Therapeutics and MultiPlan
The main advantage of trading using opposite Vivos Therapeutics and MultiPlan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, MultiPlan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MultiPlan will offset losses from the drop in MultiPlan's long position.| Vivos Therapeutics vs. Bone Biologics Corp | Vivos Therapeutics vs. Tivic Health Systems | Vivos Therapeutics vs. Bluejay Diagnostics | Vivos Therapeutics vs. Rapid Micro Biosystems |
| MultiPlan vs. National Research Corp | MultiPlan vs. Evolent Health | MultiPlan vs. Simulations Plus | MultiPlan vs. Privia Health Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |